Cubist Systematic Strategies LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 29.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,442 shares of the medical equipment provider’s stock after selling 610 shares during the period. Cubist Systematic Strategies LLC’s holdings in Intuitive Surgical were worth $1,508,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently bought and sold shares of the stock. ETF Managers Group LLC acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $110,000. Harvest Fund Management Co. Ltd acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $120,000. Parallel Advisors LLC grew its holdings in Intuitive Surgical by 3.9% in the second quarter. Parallel Advisors LLC now owns 159 shares of the medical equipment provider’s stock valued at $149,000 after purchasing an additional 6 shares during the period. Lincoln National Corp acquired a new stake in Intuitive Surgical in the third quarter valued at approximately $200,000. Finally, MUFG Americas Holdings Corp acquired a new stake in Intuitive Surgical in the third quarter valued at approximately $208,000. 32.80% of the stock is currently owned by hedge funds and other institutional investors.
Several equities analysts have recently weighed in on ISRG shares. Wedbush restated a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 10th. Barclays restated an “overweight” rating on shares of Intuitive Surgical in a research report on Friday, October 20th. Zacks Investment Research upgraded Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 target price on the stock in a research report on Tuesday, December 12th. Vetr upgraded Intuitive Surgical from a “hold” rating to a “buy” rating and set a $340.77 target price on the stock in a research report on Monday, August 28th. Finally, Canaccord Genuity restated a “hold” rating on shares of Intuitive Surgical in a research report on Tuesday, October 17th. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $335.32.
In related news, SVP Mark J. Meltzer sold 3,000 shares of the business’s stock in a transaction on Monday, November 27th. The stock was sold at an average price of $400.00, for a total transaction of $1,200,000.00. Following the completion of the transaction, the senior vice president now directly owns 9,888 shares of the company’s stock, valued at approximately $3,955,200. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Craig H. Barratt sold 15,000 shares of the company’s stock in a transaction dated Tuesday, October 24th. The stock was sold at an average price of $371.18, for a total value of $5,567,700.00. Following the transaction, the insider now directly owns 7,500 shares of the company’s stock, valued at $2,783,850. The disclosure for this sale can be found here. Insiders have sold a total of 55,944 shares of company stock valued at $21,432,971 over the last three months. 2.20% of the stock is currently owned by insiders.
Shares of Intuitive Surgical, Inc. (ISRG) opened at $369.87 on Friday. Intuitive Surgical, Inc. has a one year low of $208.24 and a one year high of $405.05. The firm has a market capitalization of $42,510.00, a price-to-earnings ratio of 47.71, a PEG ratio of 5.01 and a beta of 0.48.
Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 19th. The medical equipment provider reported $2.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.99 by $0.78. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The business had revenue of $806.10 million during the quarter, compared to analysts’ expectations of $753.25 million. During the same period in the previous year, the firm posted $2.06 earnings per share. The company’s revenue was up 18.0% on a year-over-year basis. research analysts predict that Intuitive Surgical, Inc. will post 7.85 EPS for the current fiscal year.
Intuitive Surgical Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.